Also trades as: RVPHW (NASDAQ) · $vol 0M
RVPH OTC
Reviva Pharmaceuticals Holdings, Inc.
1W: -2.2%
1M: -5.9%
3M: +9.8%
YTD: +45.2%
1Y: -33.4%
3Y: -89.9%
5Y: -87.0%
$0.38
-0.04 (-10.03%)
Weekly Expected Move ±8.0%
$0
$0
$0
$0
$0
Credit Risk of going bust: not rated, debt is over 20 times the stock's value Debt: 100.0% of company value Bonds: none of note held by US funds details ▾
Not rated: debt is over 20 times the stock market value, where the model breaks down (deep distress or a data error). Altman Z'' -21.86.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-01-26
Earliest Filing
2024-08-22
Latest Filing
partner: 5
Counterparties (Filed by RVPH)
5 relationshipsCompanies named in RVPH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Titan Partners Group LLC | KMCM | partner | Underwriter for the offering of common stock and warrants | 2024-08-22 | View |
| American Capital Partners, LLC | AIG | partner | Parent company of Titan Partners Group LLC | 2024-08-22 | View |
| Titan Partners Group LLC | KMCM | partner | Representative of the underwriters in the public offering of common stock and warrants | 2024-08-21 | View |
| American Capital Partners, LLC | AIG | partner | Parent entity of Titan Partners Group LLC, acting as a division | 2024-08-21 | View |
| H.C. Wainwright & Co., LLC | — | partner | Sales agent for At The Market Offering Agreement | 2022-01-26 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-12 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-05-13 | Delisting Notice; Other Events | View | |
| 2026-05-13 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-19 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-03-05 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2026-01-23 | Notice of Delisting or Transfer; Other Events | View | |
| 2025-12-23 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-17 | Notice of Delisting or Transfer | View | |
| 2025-09-26 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-09-19 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-08-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-26 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-06-06 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-06-02 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-05-30 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-05-15 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-31 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR